Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
As CEO, your immediate priority is patient safety, followed by ethical transparency, legal compliance, and stakeholder trust. Delaying disclosure risks lives, reputational damage, and severe legal consequences (e.g., criminal liability under the FDCA, shareholder lawsuits, or even a corporate manslaughter case).Read the full answer